Early recurrence of benign meningioma correlates with expression of mini-chromosome maintenance-2 protein

British Journal of Neurosurgery

Volumn 16, Issue 1, 2002, Pages 10-15

  Hunt, D P J ^a   Freeman, A ^b   Morris, L S ^b   Burnet, N G ^c   Bird, K ^b   Davies, T W ^a   Laskey, R A ^b   Coleman, N ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

MCM proteins; Meningioma; Proliferation; Tumour prognosis

Indexed keywords

MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 2; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RECURRENCE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; DNA BINDING; DNA REPLICATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; MENINGIOMA; MITOSIS INDEX; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANTIBODIES, MONOCLONAL; DNA REPLICATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MENINGIOMA; MIDDLE AGED; MITOTIC INDEX; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036131103     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688690120114174     Document Type: Article

References (20)

1. Meningiomas: Behaviour in vivo and in vitro
2. The recurrence of intracranial meningiomas after surgical treatment
3. The recurrence of intracranial meningiomas after surgical treatment
4. Meningiomas: Genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider lecture
5. MCM3 complex require for cell cycle regulation of DNA replication in vertebrate cells
6. Cell cycle control of DNA replication
7. Putting it all together: Building a prereplicative complex
8. Purification of an MCM-containing complex as a component of the DNA replication licensing system
9. The minichromosome maintenance proteins as biological markers of dysplasia and malignancy
10. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck
11. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma
12. Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BrdU and Ki-67, and tumour doubling time
13. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence
14. No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry
15. Prediction of recurrence in histologically benign meningiomas: Proliferating cell nuclear antigen and Ki-67 immunohistochemical study
16. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms
17. The effect of tissue fixation on immunostaining for proliferating cell nuclear antigen with the monoclonal antibody PC 10
18. Monoclonal antibody Ki-67: Its use in histopathology
19. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication
20. Analysis of genomic alterations in benign, atypical and anaplastic meningiomas: Toward a genetic model of meningioma progression